IMDX
Insight Molecular Diagnostics Inc.
Insight Molecular Diagnostics Inc. (IMDX) has 12 SEC Form 4 filings (19 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Jul 7, 2026.
The most active filer is 10% Owner BROADWOOD PARTNERS, L.P. with 7 filings. Insiders have net bought $5.7M over the trailing 6 months. The largest single insider purchase in this window was $3.0M by 10% Owner BROADWOOD PARTNERS, L.P. on Feb 10, 2026.
- Industry:Medical - Diagnostics & Research
- CEO:Joshua Riggs
- Employees:46
- HQ:Nashville, TN, US
- IPO:2015-12-30
Insider Buying
$5.7M
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Market Cap
$156.0M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| 10% Owner | Purchase | 280,381 | $982K | Apr 27 | SEC ↗ | |
| 10% Owner | Purchase | 38,880 | $137K | Apr 27 | SEC ↗ | |
| 10% Owner | Purchase | 250,923 | $913K | Apr 27 | SEC ↗ | |
| 10% Owner | Purchase | 102,057 | $352K | Apr 20 | SEC ↗ | |
| 10% Owner | Purchase | 40,114 | $143K | Apr 20 | SEC ↗ | |
| 10% Owner | Purchase | 40,690 | $158K | Apr 20 | SEC ↗ | |
BROADWOOD PARTNERS, L.P.First filing | 10% Owner | Purchase | 521,739 | $3.0M | Feb 12 | SEC ↗ |
Related companies
Insight Molecular Diagnostics Inc. is in the Healthcare sector.